The global hydroxychloroquine industry generated $1.9 billion in from 2020 to 2027. Prime determinants of growthIncrease in demand for HCQ as a potential treatment option amidst the Covid-19 pandemic and surge in cases of malaria drive the growth of the global hydroxychloroquine market. However, ban in several countries due to lack of study data and fatal side-effects of the …